PEOPLE - - Compugen makes appointment:
This article was originally published in Clinica
Noam Shani has been appointed vice-president of biology research and development for Compugen, a genomics-based drug and diagnostic discovery firm based in Tel Aviv, Israel. Dr Shani joins Compugen, who supply companies such as Abbott, Novartis and Pfizer, from Medgenics, where he served as vice-president of research and development.
You may also be interested in...
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.